InvestorsHub Logo
Followers 87
Posts 6692
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Tuesday, 11/07/2023 7:41:04 AM

Tuesday, November 07, 2023 7:41:04 AM

Post# of 42925
Recognizing that I have a long-standing, pro-biased opinion of our potential with Novavax, although neither company even hints about this prospect, I am hopeful that might start to change in two days, when Novavax is scheduled to host a conference call .

"Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023"

https://ir.novavax.com/press-releases/2023-11-02-Novavax-to-Host-Conference-Call-to-Discuss-Third-Quarter-2023-Financial-Results-and-Operational-Highlights-on-November-9,-2023

I wonder if Humanigen might also announce 'Third Quarter 2023 Financial Results and Operational Highlights' at the same time. Will we see an 8-K in this regard, which also will discuss our regulatory approval from Australia for the treatment of CMML, ahead of the scheduled December 9th presentation to the American Society of Hematology (ASH)?

But, as a current shareholder, the news that I am most anticipating is the recall of the company's loaned shares.